Enzyme Patent Dispute Settled For $8.2M
Danish biotech company Danisco A/S will pay rival Novozymes A/S over $8.2 million to settle an ongoing patent infringement suit after a district court judge ruled Monday that Danisco willfully infringed...To view the full article, register now.
Already a subscriber? Click here to view full article